Here's the live share price of Gujarat Themis Biosyn along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Gujarat Themis Biosyn has gained 58.82% CAGR. Over the past year, the corresponding return has been 15.48%.
Gujarat Themis Biosyn’s current P/E of 75.93x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Gujarat Themis Biosyn | 3.10 | -21.47 | -26.04 | -6.50 | 15.48 | 62.18 | 58.82 |
| Sun Pharmaceutical Industries | 6.87 | -4.37 | 0.70 | 6.63 | -2.57 | 19.23 | 21.85 |
| Divi's Laboratories | 1.03 | -7.91 | -8.11 | -0.27 | -0.39 | 30.55 | 10.09 |
| Torrent Pharmaceuticals | 0.97 | -2.28 | 11.69 | 11.15 | 22.66 | 37.59 | 23.72 |
| Cipla | 1.40 | -8.51 | -10.77 | -9.99 | -8.82 | 9.19 | 9.63 |
| Dr. Reddy's Laboratories | 4.42 | 2.39 | 5.56 | 5.96 | 2.55 | 12.72 | 5.55 |
| Lupin | 2.76 | -0.14 | 12.12 | 13.57 | 0.50 | 43.25 | 15.62 |
| Zydus Lifesciences | 3.99 | -0.72 | -2.46 | -2.62 | -7.38 | 24.29 | 14.23 |
| Mankind Pharma | -1.81 | -9.74 | -7.81 | -17.92 | -17.15 | 13.58 | 7.94 |
| Aurobindo Pharma | -0.91 | -2.76 | 6.97 | 12.33 | 0.80 | 42.10 | 4.65 |
| Alkem Laboratories | 1.07 | -0.98 | 1.04 | 17.54 | 11.22 | 23.21 | 14.59 |
| Biocon | 2.01 | -3.43 | -1.64 | 2.55 | -3.23 | 16.30 | -1.78 |
| Abbott India | -0.81 | -3.66 | -4.69 | -16.22 | -7.87 | 9.41 | 13.62 |
| Glenmark Pharmaceuticals | -2.23 | -6.68 | 8.65 | -4.43 | 28.04 | 71.29 | 31.42 |
| Laurus Labs | 2.09 | -12.70 | 0.28 | 17.55 | 53.63 | 43.95 | 22.52 |
| GlaxoSmithKline Pharmaceuticals | 4.74 | 2.16 | -3.07 | -6.27 | 13.91 | 26.53 | 11.47 |
| Anthem Biosciences | 12.46 | 2.67 | -3.42 | -10.30 | -7.83 | -2.68 | -1.62 |
| Ipca Laboratories | -0.97 | -3.89 | 10.08 | 4.61 | -3.40 | 19.14 | 8.42 |
| Ajanta Pharma | 2.52 | 0.03 | 13.00 | 9.11 | 6.12 | 33.94 | 18.79 |
| Gland Pharma | 2.15 | 10.35 | 1.32 | -3.67 | 24.33 | 12.94 | -4.08 |
Over the last one year, Gujarat Themis Biosyn has gained 15.48% compared to peers like Sun Pharmaceutical Industries (-2.57%), Divi's Laboratories (-0.39%), Torrent Pharmaceuticals (22.66%). From a 5 year perspective, Gujarat Themis Biosyn has outperformed peers relative to Sun Pharmaceutical Industries (21.85%) and Divi's Laboratories (10.09%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 327.66 | 326.91 |
| 10 | 322.39 | 328.88 |
| 20 | 337.81 | 342.22 |
| 50 | 380.33 | 371.28 |
| 100 | 404.19 | 382.64 |
| 200 | 373.36 | 371.15 |
In the latest quarter, Gujarat Themis Biosyn remained same as its previous close in promoter holding, while DII stake unchanged at 1.17%, FII holding fell to 1.96%, and public shareholding moved up to 26.00% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 9,96,000 | 6.31 | 43.99 | |
| 2,58,000 | 0.67 | 11.39 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Feb 07, 2026, 9:05 PM IST | Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report |
| Feb 07, 2026, 8:59 PM IST | Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot |
| Feb 05, 2026, 11:22 PM IST | Guj. Themis Bios - Announcement under Regulation 30 (LODR)-Investor Presentation |
| Feb 05, 2026, 10:38 PM IST | Guj. Themis Bios - Results - Financial Results For The Quarter And Nine Months Ended 31.12.2025 |
| Feb 05, 2026, 9:59 PM IST | Guj. Themis Bios - Announcement under Regulation 30 (LODR)-Change in Management |
Gujarat Themis Biosyn Ltd. is a Public Limited Listed company incorporated on 11/12/1981 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1981PLC004878 and registration number is 004878. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 150.80 Cr. and Equity Capital is Rs. 10.90 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Gujarat Themis Biosyn is ₹333.00 as on Feb 09, 2026.
The Gujarat Themis Biosyn is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Gujarat Themis Biosyn is ₹3,628.54 Cr as on Feb 09, 2026.
Today’s highest and lowest price of Gujarat Themis Biosyn are ₹341.00 and ₹324.90.
The 52-week high/low is the highest and lowest price at which Gujarat Themis Biosyn stock has traded in the past 52-week or nearly a year. The 52-week high of Gujarat Themis Biosyn is ₹479.45 and 52-week low of Gujarat Themis Biosyn is ₹192.35 as on Feb 09, 2026.
The Gujarat Themis Biosyn has shown returns of 2.51% over the past day, -21.47% for the past month, -26.04% over 3 months, 15.48% over 1 year, 62.18% across 3 years, and 58.82% over 5 years.
P/E ratio of and PB ratio of Gujarat Themis Biosyn are 75.93 and 13.72 on Feb 09, 2026. While the company gives a dividend yield of 0.20 per annum.